Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking
- PMID: 2174668
- DOI: 10.1146/annurev.mi.44.100190.000423
Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking
Abstract
This article reviews major developments concerning the VZV glycoproteins. Very little was published about these viral products prior to the early 1980s. VZV is now known to encode five glycoproteins that have been designated gpI through gpV. The viral glycoproteins are present within the envelope of the complete virion; in addition, they are inserted in the plasma membrane of the infected cell. Studies of the assembly and processing of three of the VZV glycoproteins have demonstrated that they may contain both N-linked and O-linked glycans, some of which are also sulfated and sialated. A heretofore unappreciated modification of VZV gpI is phosphorylation. The glycoprotein is modified on its serine and threonine residues by at least two cellular protein kinases--casein kinases I and II. Finally, aspects of viral glycoprotein trafficking have been analyzed in VZV-infected cells. The pathway progresses from the trans-Golgi region via cytoplasmic vacuoles to the outer cellular membrane. The virus may acquire part of its glycoprotein-laden envelope from the cytoplasmic vacuoles.
Similar articles
-
Phosphorylation by the varicella-zoster virus ORF47 protein serine kinase determines whether endocytosed viral gE traffics to the trans-Golgi network or recycles to the cell membrane.J Virol. 2002 Nov;76(21):10980-93. doi: 10.1128/jvi.76.21.10980-10993.2002. J Virol. 2002. PMID: 12368341 Free PMC article.
-
Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI.J Virol. 1992 Jun;66(6):3643-51. doi: 10.1128/JVI.66.6.3643-3651.1992. J Virol. 1992. PMID: 1316474 Free PMC article.
-
Phosphorylation of varicella-zoster virus glycoprotein gpI by mammalian casein kinase II and casein kinase I.J Virol. 1989 Sep;63(9):3912-8. doi: 10.1128/JVI.63.9.3912-3918.1989. J Virol. 1989. PMID: 2548005 Free PMC article.
-
Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.Mol Biol Med. 1989 Oct;6(5):453-62. Mol Biol Med. 1989. PMID: 2560525 Review.
-
VZV ORF47 serine protein kinase and its viral substrates.Curr Top Microbiol Immunol. 2010;342:99-111. doi: 10.1007/82_2009_5. Curr Top Microbiol Immunol. 2010. PMID: 20186612 Review.
Cited by
-
Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.J Virol. 2002 Aug;76(16):8468-71. doi: 10.1128/jvi.76.16.8468-8471.2002. J Virol. 2002. PMID: 12134050 Free PMC article.
-
Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells.J Virol. 2000 Dec;74(23):11377-87. doi: 10.1128/jvi.74.23.11377-11387.2000. J Virol. 2000. PMID: 11070038 Free PMC article.
-
Role of PACS-1 in trafficking of human cytomegalovirus glycoprotein B and virus production.J Virol. 2003 Oct;77(20):11105-13. doi: 10.1128/jvi.77.20.11105-11113.2003. J Virol. 2003. PMID: 14512558 Free PMC article.
-
A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.J Gen Virol. 2015 Jul;96(Pt 7):1581-602. doi: 10.1099/vir.0.000128. Epub 2015 Mar 20. J Gen Virol. 2015. PMID: 25794504 Free PMC article. Review.
-
The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.J Virol. 2012 Oct;86(19):10695-703. doi: 10.1128/JVI.01067-12. Epub 2012 Jul 25. J Virol. 2012. PMID: 22837206 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources